La carga viral y los biomarcadores químicos para evaluar la gravedad y el pronóstico en pacientes con SARS-CoV-2.

  • Francisco Xavier Poveda Paredes Universidad Regional Autónoma de Los Andes
  • Marcel Alexander Núñez Peralvo Universidad Regional Autónoma de Los Andes
  • Enrique Alexander Elizalde Enríquez Universidad Regional Autónoma de Los Andes
Palabras clave: SARS-Cov-2, Biomarcadores, Carga Viral, Laboratory, Pronóstico COVID-19

Resumen

Este trabajo es una revisiónbibliográfica de artículoscientíficos de alto impacto que se han publicado en los últimos meses sobre el SARS-CoV-2. Se ha reportado que el COVID-19 tiene una alta transmisibilidad y mortalidad, y por ser un virus emergente se han realizado investigaciones sobre sus mecanismos de virulencia y patología; por esta razón, en este estudio se detalla minuciosamente las características moleculares, fisiopatología y la respuesta inmunitaria del paciente frente a la infección, ya que puede ser exacerbada y causar falla multiorgánica desatando el aumento de biomarcadores inflamatorios y de coagulación, que tienen que ser interpretados por el tratante debido a que el aumento exponencial de ferritina, D-Dimero, LDH, Procalcitonina (PCT), se correlacionan como de mal pronóstico del paciente.

Citas

Akhmerov, Akbarshakh, y Eduardo Marban. (2020). «COVID-19 and the Heart». Circulation Research 126(10):1443-55.

Cao, Xuetao. (2020). «COVID-19: Immunopathology and Its Implications for Therapy». Nature Reviews Immunology 20(5):269-70.

Chen, Huarong, Weixin Liu, Dabin Liu, Liuyang Zhao, y Jun Yu. (2020). «SARS-CoV-2 Activates Lung Epithelia Cell Proinflammatory Signaling and Leads to Immune Dysregulation in COVID-19 Patients by Single-Cell Sequencing». MedRxiv 2020.05.08.20096024.

Chen, Nanshan, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei, Jia’an Xia, Ting Yu, Xinxin Zhang, y Li Zhang. (2020b). «Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study». The Lancet 395(10223):507-13.

Chen, Tao, Di Wu, Huilong Chen, Weiming Yan, Danlei Yang, Guang Chen, Ke Ma, Dong Xu, Haijing Yu, Hongwu Wang, Tao Wang, Wei Guo, Jia Chen, Chen Ding, Xiaoping Zhang, Jiaquan Huang, Meifang Han, Shusheng Li, Xiaoping Luo, Jianping Zhao, y Qin Ning. 2020a. «Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study». BMJ 368:1091.

Connors, J. M., & Levy, J. H. (2020). COVID-19 and its implications for thrombosis and anticoagulation. Blood, TheJournalofthe American SocietyofHematology, 135(23), 2033-2040.

Han, Huan, Lan Yang, Rui Liu, Fang Liu, Kai Lang Wu, Jie Li, Xing Hui Liu, y Cheng Liang Zhu. (2020). «Prominent Changes in Blood Coagulation of Patients with SARS-CoV-2 Infection». Clinical Chemistry and Laboratory Medicine 58(7):1116-20.

Henry, Brandon, Maria Oliveira, Stefanie Benoit, Mario Plebani, y Giuseppe Lippi. (2020). «Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis». Clinical Chemistry and Laboratory Medicine 58(7):1021-28.

Hoffmann, Markus, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S. Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche, Marcel A. Müller, Christian Drosten, y Stefan Pöhlmann. (2020). «SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor». Cell 181(2):271-80.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Thelancet, 395(10223), 497- 506.

Issa, Elio, Georgi Merhi, BaligPanossian, Tamara Salloum, y Sima Tokajian. (2020). «SARS- CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis». MSystems 5(3):00266-20.

Lauer, Stephen A., Kyra H. Grantz, Qifang Bi, Forrest K. Jones, Qulu Zheng, Hannah Meredith, Andrew S. Azman, Nicholas G. Reich, y Justin Lessler. (2020). «The Incubation Period of 2019-NCoV from Publicly Reported Confirmed Cases: Estimation and Application». MedRxiv 172(9):577-82.

Li, Hui, Liang Liu, Dingyu Zhang, Jiuyang Xu, Huaping Dai, Nan Tang, Xiao Su, y Bin Cao. (2020). «SARS-CoV-2 and Viral Sepsis: Observations and Hypotheses». The Lancet 395(10235):1517-20.

Lippi, Giuseppe, y Mario Plebani. (2020). «Procalcitonin in Patients with Severe Coronavirus Disease 2019 (COVID-19): A Meta-Analysis». ClinicaChimica Acta; International Journal of Clinical Chemistry 505:190-91.

Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., ... &Xiong, L. (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS- CoV-2 infected patients. EBioMedicine, 102763.

McGonagle, Dennis, James S. O’Donnell, Kassem Sharif, Paul Emery, y Charles Bridgewood. (2020). «Immune Mechanisms of Pulmonary Intravascular Coagulopathy in COVID-19 Pneumonia». The Lancet Rheumatology.

Mohamed, Muner MB, Ivo Lukitsch, Aldo E. Torres-Ortiz, Joseph B. Walker, VipinVarghese, Cesar F. Hernandez-Arroyo, MuhannadAlqudsi, Jason R. LeDoux, y Juan Carlos Q. Velez. (2020). «Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans». Kidney360 10.34067/KID.0002652020.

Moher, David, Alessandro Liberati, Jennifer Tetzlaff, Douglas G. Altman, y The PRISMA Group. (2009). «Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement». PLOS Medicine 6(7).

Peberdy Mary Ann, Cretikos Michelle, Abella Benjamin S., DeVita Michael, Goldhill David, Kloeck Walter, Kronick Steven L., Morrison Laurie J., Nadkarni Vinay M., Nichol Graham, Nolan Jerry P., Parr Michael, Tibballs James, van der Jagt Elise W., y Young Lis. (2007). «Recommended Guidelines for Monitoring, Reporting, and Conducting Research on Medical Emergency Team, Outreach, and Rapid Response Systems: An Utstein-Style Scientific Statement». Circulation 116(21):2481-2500.

Ranucci, M., Ballotta, A., Di Dedda, U., Bayshnikova, E., Dei Poli, M., Resta, M., ... &Menicanti, L. (2020). The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. JournalofThrombosis and Haemostasis.

Sethuraman, Nandini, SundararajStanleyraj Jeremiah, y AkihideRyo. (2020). «Interpreting Diagnostic Tests for SARS-CoV-2». JAMA 323(22):2249-51.

Shi, Fengjuan, Tao Wu, Xiaojuan Zhu, Yiyue Ge, Xiaoyan Zeng, Ying Chi, Xuefei Du, Liguo Zhu, Fengcai Zhu, Baoli Zhu, Lunbiao Cui, y Bin Wu. (2020). «Association of Viral Load with Serum Biomakers among COVID-19 Cases». Virology 546:122-26.

Takami, Akiyoshi. (2020). «Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19». International Journal of Hematology 112(1):122-24.

Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., ... & Cui, J. (2020). On the origin and continuing evolution of SARS-CoV-2. National Science Review.

Tay, Matthew Zirui, Chek Meng Poh, Laurent Rénia, Paul A. MacAry, y Lisa F. P. Ng. (2020). «The Trinity of COVID-19: Immunity, Inflammation and Intervention». Nature Reviews Immunology 20(6):363-74.

To, K. K. W., Tsang, O. T. Y., Leung, W. S., Tam, A. R., Wu, T. C., Lung, D. C., ... & Lau, D. P. L. (2020a). Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet InfectiousDiseases.

Ulhaq, ZulvikarSyambani, y Gita Vita Soraya. 2020. «Interleukin-6 as a Potential Biomarker of COVID-19 Progression». Medecine Et Maladies Infectieuses 50(4):382-83.

Van Dorp, Lucy, MislavAcman, Damien Richard, Liam P. Shaw, Charlotte E. Ford, Louise Ormond, Christopher J. Owen, Juanita Pang, Cedric C. S. Tan, Florencia A. T. Boshier, Arturo Torres Ortiz, y François Balloux. (2020). «Emergence of Genomic Diversity and Recurrent Mutations in SARS-CoV-2». Infection, Genetics and Evolution 83:104351.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Zhao, Y. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.

WHO (2020). Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., ... & Song, J. (2020a). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine.

Wu, Fan, Aojie Wang, Mei Liu, Qimin Wang, Jun Chen, Shuai Xia, Yun Ling, Yuling Zhang, Jingna Xun, Lu Lu, ShiboJiang, Hongzhou Lu, YumeiWen, y Jinghe Huang. (2020). Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications. SSRN Scholarly Paper. ID 3566211. Rochester, NY: Social Science Research Network.

Yang, Xiaobo, Yuan Yu, Jiqian Xu, Huaqing Shu, Jia’an Xia, Hong Liu, Yongran Wu, Lu Zhang, Zhui Yu, Minghao Fang, Ting Yu, Yaxin Wang, Shangwen Pan, Xiaojing Zou, Shiying Yuan, y You Shang. (2020). «Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study». The Lancet Respiratory Medicine 8(5):475-81.

Yilla, Mamadi, Brian H. Harcourt, Carole J. Hickman, Marcia McGrew, AzaibiTamin, Cynthia S. Goldsmith, William J. Bellini, y Larry J. Anderson. (2005). «SARS-Coronavirus Replication in Human Peripheral Monocytes/Macrophages». Virus Research 107(1):93-101.

Yin, Shiyu, Ming Huang, Dengju Li, y Ning Tang. (2020). «Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2». Journal of Thrombosis and Thrombolysis 1-4.

Yu, F., Yan, L., Wang, N., Yang, S., Wang, L., Tang, Y., ... & Wang, F. (2020). Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. ClinicalInfectiousDiseases.

Yue, Yuan, Neel R. Nabar, Chong-Shan Shi, Olena Kamenyeva, Xun Xiao, Il-Young Hwang, Min Wang, y John H. Kehrl. (2018). «SARS-Coronavirus Open Reading Frame-3a Drives Multimodal Necrotic Cell Death». Cell Death & Disease 9(9):1-15.

Zhang, H., Wang, X., Fu, Z., Luo, M., Zhang, Z., Zhang, K., ... y Yan, X. (2020). Factores potenciales para la predicción de la gravedad de la enfermedad de pacientes con COVID- 19. MedRxiv .

Zheng, Meijuan, Yong Gao, Gang Wang, GuobinSong, Siyu Liu, DandanSun, YuanhongXu, y ZhigangTian. (2020). «Functional Exhaustion of Antiviral Lymphocytes in COVID-19 Patients». Cellular & Molecular Immunology 17(5):533-35.

Zhou, Fei, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, y Bin Cao. (2020a). «Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study». The Lancet 395(10229):1054-62.

Publicado
2020-09-01